Literature DB >> 35098434

miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms.

Prabhsimran Kaur1, Sushil Kotru2, Sandeep Singh3, Anjana Munshi4.   

Abstract

A worldwide failure to achieve glycemic targets has led to complications associated with diabetes mellitus. In addition to genetic and other risk factors, epigenetic factors like DNA methylation, histone modifications, and non-coding RNAs play a significant part in the pathogenesis of complications. Among non-coding RNAs, miRNAs have been explored extensively since they control various biological processes. Their dysregulation has been implicated in various diseases including diabetic complications. Diabetic retinopathy and nephropathy are two common microvascular diabetic complications. Diabetic retinopathy affects the retina of the eye whereas nephropathy damages kidneys on account of prolonged hyperglycemia. This review aims to evaluate the role of miRNAs in diabetic retinopathy and diabetic nephropathy with an emphasis on the dysregulation of various pathways involved. In addition, the role of significant miRNAs as biomarkers for the diagnosis and prognosis of complications has also been discussed. Further, an update on the role of important miRNAs as potential therapeutic modalities has been given.
© 2021. The Author(s) under exclusive licence to University of Navarra.

Entities:  

Keywords:  Diabetic complications; Diabetic nephropathy; Diabetic retinopathy; Microvascular complications; Non-coding RNAs; miRNAs

Mesh:

Substances:

Year:  2022        PMID: 35098434     DOI: 10.1007/s13105-021-00867-0

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  95 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 2.  Vascular endothelial growth factor biology: clinical implications for ocular treatments.

Authors:  R B Bhisitkul
Journal:  Br J Ophthalmol       Date:  2006-12       Impact factor: 4.638

3.  The pathobiology of diabetic complications: a unifying mechanism.

Authors:  Michael Brownlee
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

Review 4.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

Review 5.  The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy.

Authors:  Alistair J Barber; Thomas W Gardner; Steven F Abcouwer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

Review 6.  The Trk family of neurotrophin receptors.

Authors:  M Barbacid
Journal:  J Neurobiol       Date:  1994-11

7.  Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.

Authors:  Yugal Behl; Padmaja Krothapalli; Tesfahun Desta; Amanda DiPiazza; Sayon Roy; Dana T Graves
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

8.  Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease.

Authors:  K S Amr; H Abdelmawgoud; Z Y Ali; S Shehata; H M Raslan
Journal:  Br J Biomed Sci       Date:  2018-02-16       Impact factor: 3.829

9.  Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells.

Authors:  A P Adamis; D T Shima; K T Yeo; T K Yeo; L F Brown; B Berse; P A D'Amore; J Folkman
Journal:  Biochem Biophys Res Commun       Date:  1993-06-15       Impact factor: 3.575

Review 10.  Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy.

Authors:  Abdullah S Al-Kharashi
Journal:  Saudi J Ophthalmol       Date:  2018-05-29
View more
  1 in total

Review 1.  Lupus nephritis: The regulatory interplay between epigenetic and MicroRNAs.

Authors:  Ning Xu; Jie Liu; Xiangling Li
Journal:  Front Physiol       Date:  2022-09-16       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.